Latest Drug test Stories

Industry Leader in Breath Alcohol Test Equipment creates new position to accelerate company growth into new markets. (PRWEB) January 04, 2012 Denver, Colorado: Lifeloc Technologies, a leader in the manufacture of portable breath alcohol testing devices for Medical, Workplace and Law Enforcement use, has named G “Ravi” Ravishankar as its Vice President of New Ventures and Acquisitions. Ravi will be responsible for the identification and acquisition of new technologies and new...

MOGADORE, Ohio, Dec. 20, 2011 /PRNewswire/ -- Omega Laboratories, Inc. announced that it has become the first and only laboratory to receive 510(k) clearance from the Food and Drug Administration (FDA) for its Extended Opiates Test that detects the use of Oxycodone and Hydrocodone through human hair analysis. The clearance also included the test for Codeine, Morphine and Heroin. The ability to test for Oxycodone (eg. OxyContin® and Percocet®)* and Hydrocodone (eg. Vicodin®...

OXFORD, England, November 14, 2011 /PRNewswire/ -- Concateno launches next-generation roadside drug testing device at Medica 2011 International police forces will now be able to target drug drivers quicker and easier, following the launch of a new roadside drug testing device developed by Concateno, Europe's leading drug and alcohol testing company. The Alere(TM) DDS(R)2 Mobile Test System, Concateno's next-generation handheld drug...

The world’s first prototype of a hand-held fingerprint drug testing device has been created by University of East Anglia spin-out company Intelligent Fingerprinting. The unique device detects drugs and other substances from the sweat contained in fingerprints and will enable mobile testing with instant results. Intelligent Fingerprinting Ltd is based in the NRP Innovation Centre at Norwich Research Park. The company developed the prototype with eg technology – a product design,...

University Services, a Toxicology Services company, has reviewed over 1 million drug screens for physicians treating patients with chronic pain by determining inconsistencies between what a patient was prescribed versus what was found in their system. Philadelphia, PA (PRWEB) November 07, 2011 The Institute of Medicine Report from the Committee on Advancing Pain Research, Care, and Education, states chronic pain affects 116 million Americans each year. According to the American Academy of...

JERUSALEM, Oct. 24, 2011 /PRNewswire/ -- IDenta Corp. (OTC: IDTA) CEO Yaacov Shoham today made the following major announcement. Mr. Shoham stated, "We have known that the General Screening Kit was able to detect the presence of 21 different illicit drugs, but recently we have discovered that this powerful kit can also detect the presence of synthetic drugs and cannabinoid products. The synthetic drugs and the cannabinoid products are creating a new huge problem worldwide because they are...

Urgently needed tests which could help identify the manufacturers of designer 'legal high' drugs are being developed in research led at the University of Strathclyde in Glasgow. The drugs, known by names such as 'ivory wave' and NRG-1" and sold labelled as bath salts, plant food and incense, mimic the effects of illegal drugs such as amphetamine, cocaine and ecstasy. Although these so-called 'designer drugs' can be dangerous, many have not yet been made illegal and are difficult to detect...

Drugged Driving Summit to be Held October 14 WASHINGTON, Oct. 13, 2011 /PRNewswire-USNewswire/ -- The Governors Highway Safety Association (GHSA) announced today that it has strengthened its drugged driving policy during its recent Annual Meeting, held September 25-28 in Cincinnati. The new policy supports elevating drugged driving to a national priority and calls upon states to undertake several strategies to address this emerging highway safety issue. GHSA wants states to implement...

MADISON, N.J., Oct. 11, 2011 /PRNewswire/ -- American workers continue to use prescription opiates at relatively high levels, according to Drug Testing Index(TM) (DTI) data released today by Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services. Hydrocodone and oxycodones remain the most detected prescription opiates in the U.S. general workforce, with 1.3% and 1.1% positivity rates, respectively, in the first half of 2011....

INDIANAPOLIS, Oct. 10, 2011 /PRNewswire/ -- Chronic pain affects an estimated 116 million adults in the U.S.--more than the number affected by heart disease, diabetes, and cancer combined, according to a recent report by the Institute of Medicine. At the same time, prescriptions for opioids have increased over the last ten years by 48%, contributing to the nation's growing battle with prescription drug abuse, according to a report by the U.S. Food and Drug Administration. As a result,...